NCT05085717

Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children

Name: Clinical Trial NCT05085717
Creator: Raincy Montfermeil Hospital Group
Keywords: HIV Infection, clinical trial, France

Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children, Acceptability and Determinants of a Male Prenatal Consultation, Including Screening, Catch-up Vaccination and Access to Social Rights, for Fathers Unborn Children at Montreuil Hospital,

Raincy Montfermeil Hospital Group·ClinicalTrials.govRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: HIV Infection
Study type: Observational

Sponsor & location

Primary sponsor: Raincy Montfermeil Hospital Group
Location: Montreuil, France

Timeline & enrollment

Phase: N/A
Start date: Mar 17, 2021
End date: Mar 01, 2024
Enrollment: 960 participants

Primary outcome

evaluation of the proportion of fathers-to-be who fathers who accepted prenatal consultation among

Summary

Insufficient screening and diagnostic delay play a significant role in sustaining the HIV epidemic by France.  Gender inequalities major factors reinforce social inequalities in order to of heterosexual men born abroad the most later diagnosed with HIV infection. Those gender differences are largely due to efficiency antenatal HIV screening, offered to women every pregnancy and widely accepted: a billed HIV serology in the context of pregnancy monitoring was found for 92% pregnant women benefiting from health insurance in 2015 the health of men is not taken into account in prenatal follow-up current French. The maternity hospital drains a population largely immigrant, often precarious The male prenatal consultation exists but it is not organized: it is possible to implement it, provided that the constraints exerted on men are taken into account.  the projet study the feasibility and the implementation processes place of prenatal consultation of future fathers

ICD-10 classifications

HIV disease resulting in other viral infectionsHuman immunodeficiency virus [HIV] diseaseHIV disease resulting in other bacterial infectionsAcute HIV infection syndromeUnspecified human immunodeficiency virus [HIV] disease

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05085717
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05085717 through Pure Global AI's free database. This phase not specified trial is sponsored by Raincy Montfermeil Hospital Group and is currently Recruiting. The study focuses on HIV Infection. Target enrollment is 960 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.